Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo

Immunological Reviews

Volumn 156, Issue , 1997, Pages 67-78

  Pape, Kathryn A ^a   Kearney, Elizabeth R ^a   Khoruts, Alexander ^a   Mondino, Anna ^a   Merica, Rebecca ^a   Chen, Zong Ming ^a   Ingulli, Elizabeth ^a   White, Jennifer ^a   Johnson, Julia G ^a   Jenkins, Marc K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; LYMPHOKINE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; CELL FUNCTION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

EID: 16944365812     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00959.x     Document Type: Review

References (59)

1. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 1994;12:555-592.
2. Mondino A, Jenkins MK. Surface proteins involved in T cell costimulation. J Leuk Biol 1994;55:805-815.
3. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
4. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-490.
5. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251.
6. Tse HY, Schwartz RH, Paul WE. Cell-cell interactions in the T cell proliferative response. J Immunol 1980;125:401-500.
7. Kappler JW, et al. A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex product. Cell 1987;49:263-271.
8. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991;349:245-248.
9. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 1990;63:1249-1256.
10. Perkins DL, Wang Y, Ho S, Wiens GR, Seidman JG, Rimm IJ. Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (β-chain) transgenic mice. J Immunol 1993;150:4284-4291.
11. + T cells in staphylococcus enterotoxin B-primed mice. J Exp Med 1990;172:1065-1070.
12. Miethke T, Wahl C, Heeg K, Echtenacher B, Drammer PH, Wagner H. T cell mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of TNF. J Exp Med 1992;175:91-98.
13. Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol 1993;23:1956-1962.
14. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
15. Hedrick SM, et al. Selection of amino acid sequences in the beta chain of the T cell antigen receptor. Science 1988;239:1541-1544.
16. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995;268:106-111.
17. lo thymocytes in vivo. Science 1990;250:1720-1723.
18. Haskins K, Kubo R, White J, Pigeon M, Kappler J, Marrack P. The MHC-restricted antigen receptor on T cells. I. Isolation of a monoclonal antibody. J Exp Med 1983;157:1149-1169.
19. Lee WT, Cole-Calkins J, Street NE. Memory T cell development in the absence of specific antigen priming. J Immunol 1996;157:5300-5307.
20. + T cells. J Immunol 1990;144:3288-3295.
21. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995;57:827-872.
22. Gretz JE, Kaldjian EP, Anderson AO, Shaw S. Sophisticated strategies for information encounter in the lymph node. J Immunol 1996;157:495-499.
23. Tew JG, Burton GF, Kupp LI, Szakal A. Follicular dendritic cells in germinal center reactions. Adv Exp Med Biol 1993;329:461-465.
24. Dresser DW. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature 1961;191:1169-1171.
25. Freund J, Casals J, Hosmer EP. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 1937;37:509-513.
26. Chiller JM, Habicht GS, Weigle WO. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 1961;171:813-815.
27. Parks DE, Weigle WO. Current perspectives on the cellular mechanisms of immunologic tolerance. Clin Exp Immunol 1980;39:257-262.
28. Gulbranson-Judge A, MacLennan ICM. Sequential antigen-specific growth of T cells in the T zones and follicles in response to pigeon cytochrome c. Eur J Immunol 1996;26:1830-1837.
29. Fuller KA, Kanagawa O, Nahm MH. T cells within germinal centers are specific for the immunizing antigen. J Immunol 1993;151:4505-4512.
30. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J Immunol 1995;155:1032-1036.
31. Trinchieri G. IL-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
32. Eynon EE, Parker DC. Parameters of tolerance induction by antigen targeted to B lymphocytes. J Immunol 1993;151:2958-2964.
33. Morris SC, Lees A. Holmes JM, Jeffries RDA, Finkelman FD. Induction of B cell and T cell tolerance in vivo by anti-CD32 mAb. J Immunol 1994;152:3726-3776.
34. Morris SC, Lees A, Finkelman FD. In vivo activation of naive T cells by antigen-presenting B cells. J Immunol 1994;152:3777-3785.
35. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science 1992;258:1156-1159.
36. Yuschenkoff VN, Sethna MP, Freeman GJ, Parker DC. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J Immunol 1996;157:1987-1995.
37. Inaba K, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-1860.
38. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
39. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996;157:1406-1414.
40. De Smedt T, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-1424.
41. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 1995;181:2237-2247.
42. Cumberbatch M, Kimber I. Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84:31-35.
43. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowrey RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992;176:1215-1220.
44. Koide SL, Inaba K, Steinman R. Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J Exp Med 1987;165:515-530.
45. McLellan AD, Sorg RV, Williams LA, Hart DNJ. Human dendritic cells activate T lymphocytes via a CD40:CD40 ligand-dependent pathway. Eur J Immunol 1996;26:1204-1210.
46. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995;378:617-620.
47. Grewal IS, et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864-1867.
48. Yang Y, Wilson JM. CD40 ligand-dependent T-cell activation: Requirement of B7-CD28 signaling through CD40. Science 1996;273:1862-1864.
49. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-258.
50. Liu Y, Janeway CA Jr. Microbial induction of co-stimulatory activity for CD4 T-cell growth. Int Immunol 1991;3:323-332.
51. Epstein MM, Rosa FD, Jankovic D, Sher A, Matzinger P. Successful T cell priming in B cell-deficient mice. J Exp Med 1995;182:915-922.
52. Vella AT, Scherer MT, Shultz L, Kappler JW, Marrack P. B cells are not essential for peripheral T-cell tolerance induction. Proc Natl Acad Sci USA 1996;93:951-955.
53. Picker LJ, Siegelman MH. Lymphoid tissues and organs. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1993:145-197.
54. + T cells. Annu Rev Immunol 1994;12:635-673.
55. Wolf SF, Sieburth D, Sypek J. Interleukin 12: A key modulator of immune function. Stem Cells 1994;12:154-168.
56. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Gottfried A. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-752.
57. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity of Leishmania major. Immunity 1996;4:283-289.
58. Van Houten N, Blake SF. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 1996;157:1337-1341.
59. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune privileged site. J Immunol 1996;157:2262-2271.